Dr. Luke J. McLellan Profile

Dr. Luke J. McLellan

at Univ of Dundee

SPIE Involvement:

Author

Publications (1)

This will count as one of your downloads.

You will have access to both the presentation and article (if available).

DOWNLOAD NOW

This content is available for download via your institution's subscription. To access this item, please sign in to your personal account.

Email or Username Forgot your username?

Password Forgot your password?

Show

Keep me signed in

No SPIE account? Create an account

Proceedings Article | 14 August 2019 Presentation

Standard erythemal dose (SED) and UVA exposure during daylight photodynamic therapy (Conference Presentation)

Luke McLellan

Proceedings Volume 11070, 11070BF (2019) https://doi.org/10.1117/12.2525725

KEYWORDS: Ultraviolet radiation, Surface conduction electron emitter displays, Photodynamic therapy, Data conversion, Visible radiation, Skin cancer

Read Abstract +

Daylight photodynamic therapy (dPDT) is widely used in Europe for field-change actinic keratosis (AK). Within 30 minutes of topical photosensitiser prodrug application to AK, solar illumination commences, inducing a photochemical reaction. dPDT is as effective as conventional PDT but allows large field treatment, with reduced pain; resulting in clinician and patient preference. As AK result from chronic UV exposure, it is important to limit ultraviolet (UV) radiation exposure during dPDT. Historical illuminance, irradiance and erythema-weighted irradiance data from 2013 to 2017, covering 12 locations in the UK and Europe were obtained from Public Health England. Data were converted into protoporphyrin-IX (PpIX) weighted dose, UVA exposure and erythema-effective dose assuming a 2 hour dPDT treatment. Results were subsequently averaged for each time period during a calendar month. Analysis was performed evaluating the UV exposures during viable dPDT periods, assuming a minimum threshold dose of 4 Jcm-2. The maximum average UV exposure for the UK was 8.2 standard erythemal dose (SED) in July between 1200 and 1400 in Camborne (UVA dose 25.4 Jcm-2, PpIX dose of 23.4 Jcm-2). For the same location and month between 0900 and 1100, a reduced exposure of 5.2 SED, with PpIX dose of 18.2Jcm-2 occurred. In November, at the same location between 1200 and 1400, average UV exposure was 0.8 SED and PpIX dose of 7.1 Jcm-2. Thus, visible light levels can still be high enough for effective dPDT during periods of relatively low UV exposure, which is important, particularly when treating patients at high risk of skin cancer.

My Library

You currently do not have any folders to save your paper to! Create a new folder below.

Folder Name

Folder Description

View contact details

UPDATE YOUR PROFILE

Is this your profile? Update it now.

Sign into your SPIE.org account

Don’t have a profile and want one?

Create an account on SPIE.org

Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks. You are receiving this notice because your organization may not have SPIE eBooks access.*

*Shibboleth/Open Athens users─please sign in to access your institution's subscriptions.

To obtain this item, you may purchase the complete book in print or electronic format on SPIE.org.

ORGANIZATIONAL
Sign in with credentials provided by your organization.

Organizational Username

Organizational Password

Show/Hide Password

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members:

Non-members: ADD TO CART

Keywords/Phrases

Search In:

Publication Years